维莱布兰德因子作为微血管血栓形成的生物标志物
Hinde El Otmani1, Rowan Frunt1, Simone Smits1
1Central Diagnostic Laboratory Research, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Blood
|January 25, 2024
概括
在血栓性血栓塞性紫外线 (TTP) 发作期间,从微血栓中释放出由等离子体分裂的·威勒布兰德因子 (VWF). 这种裂开的VWF (cVWF) 在ADAMTS13缺乏时可以作为微血管血栓形成的生物标志物.
科学领域:
- 血液学 血液学 血液学
- 血栓形成研究研究
- 生物标志物发现发现
背景情况:
- ·威勒布兰德因子 (VWF) 在微血管血栓形成中至关重要.
- 缺乏ADAMTS13会导致血栓性血栓细胞缺陷性紫外线 (TTP),导致微血栓症.
- 在TTP发作期间观察到等离子体激活和等离子体活性,这表明等离子体调节VWF血栓性.
研究的目的:
- 调查等离子体分裂的VWF (cVWF) 作为微血管血栓形成的潜在生物标志物.
- 开发一种能够区分cVWF与完整和ADAMTS13裂纹的VWF的生物试验.
- 评估cVWF在TTP患者和临床前模型中的临床相关性.
主要方法:
- 基于仅重链抗体 (VHH) 生物测试的可变域的开发.
- 使用微小血栓在体外降解方法验证试验.
- 对TTP患者急性发作和缓解期血样本的分析.
- 在TTP与治疗性等离子素激活的小鼠模型中的评估.
主要成果:
- 基于VHH的生物测试成功地将cVWF与其他VWF形式区分开来.
- 在TTP患者中,在急性发作期间检测到内源性cVWF,但在缓解期没有.
- 在小鼠TTP模型中,cVWF形成由治疗性等离子原激活放大,与VWF清除相关.
- 在微血管封闭的背景下,cVWF从微血栓释放出来.
结论:
- 塑切割VWF (cVWF) 是微血栓降解的特定指标.
- cVWF是微血管血栓形成的宝贵生物标志物,特别是在TTP等疾病中.
- 这些发现突显了等离子素在VWF调节中的作用,并建议针对等离子素激活的治疗策略.
相关概念视频
01:16Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
698
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
698
01:22Formation of the Platelet Plug
6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
7.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.7K